Quotient (QTNT) Tops Q4 EPS by 18c

Go back to Quotient (QTNT) Tops Q4 EPS by 18c

Quotient Limited Reports Continued Progress on the Development of MosaiQâ„¢ and Fourth Quarter and Fiscal Year 2016 Financial Results

May 23, 2016 4:17 PM EDT

Completed commissioning of initial manufacturing system for MosaiQTM consumablesFirst field trial instruments received for internal evaluation and validationGenerated positive study results for remaining four serological disease screening assaysHIV, HBV, HCV and West Nile virus successfully detected using the MosaiQ methodology for molecular disease screeningFiscal fourth quarter product sales of $4.5M, exceeding guidance

JERSEY, Channel Islands, May 23, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage... More